CIK 0001604821
- Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010894487
- Phone
- +1 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-25 | Baynes Roy D. Director | Grant or award | +124 | 15,807 | ||
| 2024-10-25 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −691 | $118.81 | $82K | 72,709 |
| 2024-10-24 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −914 | $119.19 | $109K | 73,400 |
| 2024-10-23 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −496 | $119.09 | $59K | 74,314 |
| 2024-10-22 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −256 | $120.07 | $31K | 111,891 |
| 2024-10-22 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −199 | $120.07 | $24K | 114,065 |
| 2024-10-22 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion 10b5-1 | +1,250 | 74,810 | ||
| 2024-10-22 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −1,250 | 5,000 | ||
| 2024-10-22 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −349 | $120.07 | $42K | 207,084 |
| 2024-10-22 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −893 | $120.07 | $107K | 193,722 |
| 2024-10-22 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −454 | $120.07 | $55K | 73,560 |
| 2024-10-21 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −294 | $120.76 | $36K | 112,147 |
| 2024-10-21 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −342 | $120.76 | $41K | 114,264 |
| 2024-10-21 | Sheena Jonathan Director | Exercise or conversion 10b5-1 | +143 | 282,374 | ||
| 2024-10-21 | Sheena Jonathan Director | Exercise or conversion · Restricted Stock Unit 10b5-1 | −143 | 144 | ||
| 2024-10-21 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion 10b5-1 | +644 | 207,900 | ||
| 2024-10-21 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −467 | $120.76 | $56K | 207,433 |
| 2024-10-21 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Exercise or conversion · Restricted Stock Unit 10b5-1 | −644 | 644 | ||
| 2024-10-21 | Chapman Steven Leonard CEO AND PRESIDENT | Exercise or conversion 10b5-1 | +1,775 | 196,324 | ||
| 2024-10-21 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −1,709 | $120.76 | $206K | 194,615 |
Page 65 of 85 · 1,682 trades